Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply

Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply

Linked ContentThis article is linked to Huang et al and Shaheen et al papers. To view these articles visit https://doi.org/10.1111/apt.14266 and https://doi.org/10.1111/apt.14218.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2017-10, Vol.46 (8), p.770-771
Hauptverfasser: Shaheen, A. A., Al‐Mattooq, M., Yazdanfar, S., Burak, K. W., Swain, M. G., Congly, S. E., Borman, M. A., Lee, S. S., Myers, R. P., Coffin, C. S.
Format: Artikel
Sprache:eng
Schlagworte:
Hepatitis
Hepatitis B
Tenofovir
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked ContentThis article is linked to Huang et al and Shaheen et al papers. To view these articles visit https://doi.org/10.1111/apt.14266 and https://doi.org/10.1111/apt.14218.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14282